HK1094680A1 - Anti-inflammatory agents - Google Patents

Anti-inflammatory agents

Info

Publication number: HK1094680A1
Authority: HK; Hong Kong
Prior art keywords: carbon atoms; radical; inflammatory agents; alkyl; haloalkoxy
Prior art date: 2003-12-01

Application number

HK07101966.1A

Other languages

English (en)

Inventor

David John Grainger

David John Fox

Original Assignee

Cambridge Entpr Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-01

Filing date

2007-02-21

Publication date

2007-04-04

2003-12-01 Priority claimed from GB0327775A external-priority patent/GB0327775D0/en

2004-08-05 Priority claimed from GB0417436A external-priority patent/GB0417436D0/en

2004-08-10 Priority claimed from GB0417734A external-priority patent/GB0417734D0/en

2007-02-21 Application filed by Cambridge Entpr Ltd filed Critical Cambridge Entpr Ltd

2007-04-04 Publication of HK1094680A1 publication Critical patent/HK1094680A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Biotechnology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HK07101966.1A 2003-12-01 2007-02-21 Anti-inflammatory agents HK1094680A1 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0327775A GB0327775D0 (en)	2003-12-01	2003-12-01	Anti-inflammatory agents
GB0417436A GB0417436D0 (en)	2004-08-05	2004-08-05	Anti-inflammatory agents
GB0417734A GB0417734D0 (en)	2004-08-10	2004-08-10	Anti-Inflammatory agents
PCT/GB2004/005030 WO2005053702A2 (en)	2003-12-01	2004-11-30	Anti-inflammatory agents

Publications (1)

Publication Number	Publication Date
HK1094680A1 true HK1094680A1 (en)	2007-04-04

Family

ID=34657584

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK07101966.1A HK1094680A1 (en)	2003-12-01	2007-02-21	Anti-inflammatory agents

Country Status (17)

Country	Link
US (1)	US20080227724A1 (de)
EP (2)	EP1691814B9 (de)
JP (1)	JP5248779B2 (de)
KR (1)	KR101228268B1 (de)
CN (1)	CN103393691A (de)
AR (1)	AR047730A1 (de)
CA (1)	CA2547651C (de)
CY (1)	CY1113171T1 (de)
DK (1)	DK1691814T3 (de)
ES (1)	ES2390272T3 (de)
HK (1)	HK1094680A1 (de)
IL (1)	IL175857A0 (de)
PL (1)	PL1691814T3 (de)
PT (1)	PT1691814E (de)
SI (1)	SI1691814T1 (de)
TW (1)	TWI356821B (de)
WO (1)	WO2005053702A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2418426A (en)	2004-08-18	2006-03-29	Univ Cambridge Tech	Alpha-(acylamino)-bicyclolactam derivatives for treatment of inflammatory disorders
AU2011226837B2 (en) *	2004-09-02	2014-09-18	Cambridge Enterprise Limited	Ligands for G-protein coupled receptors
GB2418427A (en) *	2004-09-02	2006-03-29	Univ Cambridge Tech	Ligands for G-protein coupled receptors
GB0512238D0 (en) *	2005-06-15	2005-07-27	Univ Cambridge Tech	Anti-inflammatory agents
US7662967B2 (en)	2007-08-02	2010-02-16	Cambridge Enterprise Limited	Anti-inflammatory compounds and compositions
GB2452696B (en)	2007-08-02	2009-09-23	Cambridge Entpr Ltd	3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
GB2455539B (en) *	2007-12-12	2012-01-18	Cambridge Entpr Ltd	Anti-inflammatory compositions and combinations
GB201009603D0 (en) *	2010-06-08	2010-07-21	Cambridge Entpr Ltd	Anti-inflammatory agent
WO2013123290A1 (en) *	2012-02-15	2013-08-22	Anida Pharma Inc.	Methods of treating amyotrophic lateral sclerosis
CN110325185A (zh) *	2017-01-18	2019-10-11	巴塞罗那自治大学	用于治疗神经退行性疾病和/或自身免疫性疾病的专门的促消退脂质介质

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB327775A (en)	1929-01-21	1930-04-17	John Harry Grayson	Improvements in thermostats
BE402700A (de)	1933-06-02
US3754026A (en) *	1969-10-17	1973-08-21	Allied Chem	Fluorocarbon amides
JPS53121781A (en) *	1977-03-30	1978-10-24	Torii Yakuhin Kk	Caprolactum derivatives
JPS625994A (ja) *	1985-07-02	1987-01-12	Toray Ind Inc	リジン誘導体の製造法
EP0312157A3 (de) *	1987-10-13	1990-07-25	Merck & Co. Inc.	Tetrapeptid-Renin-Inhibitoren mit C-terminalen Aminosäureamiden
JP3054738B2 (ja) *	1988-07-22	2000-06-19	武田薬品工業株式会社	チアゾロ［５，４―ｂ］アゼピン誘導体
DK316989D0 (da)	1989-06-26	1989-06-26	Novo Nordisk As	Enzymer
US5430022A (en) *	1990-05-14	1995-07-04	Fujisawa Pharmaceutical Co., Ltd.	Peptide compound and its preparation
IT1247698B (it) *	1990-06-21	1994-12-30	Sigma Tau Ind Farmaceuti	1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
IT1254471B (it) *	1992-02-27	1995-09-25	Magis Farmaceutici	Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento
US5821231A (en) *	1993-12-06	1998-10-13	Cytel Corporation	CS-1 peptidomimetics, compositions and methods of using same
US5929067A (en) *	1995-02-22	1999-07-27	Novartis Ag	1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
SG64939A1 (en) *	1995-07-17	2002-02-19	Mitsui Chemicals Inc	Olefin polymerization catalyst, process for preparing olefin polymer, and olefin polymer
JP3633060B2 (ja)	1995-09-22	2005-03-30	Ｊｓｒ株式会社	低結晶性エチレン系ランダム共重合体およびその組成物
US5817757A (en) *	1995-10-30	1998-10-06	Merck & Co., Inc.	Inhibitors of peptide binding to MHO class II proteins
AU714324B2 (en) *	1995-11-28	2000-01-06	Cephalon, Inc.	D-amino acid derived inhibitors of cysteine and serine proteases
MY132550A (en) *	1996-08-22	2007-10-31	Novartis Ag	Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB9621836D0 (en) *	1996-10-19	1996-12-11	Zeneca Ltd	Peptide compounds
CN1616432A (zh) *	1996-12-23	2005-05-18	伊兰药品公司	化合物、其用途以及含有所述化合物的药物组合物
US6989435B2 (en)	1997-09-11	2006-01-24	Cambridge University Technical Services Ltd.	Compounds and methods to inhibit or augment an inflammatory response
US6506782B1 (en) *	1998-02-27	2003-01-14	Athena Neurosciences, Inc.	Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
DE69929877T2 (de) *	1998-03-20	2006-08-10	Daiichi Asubio Pharma Co., Ltd.	BENZOCHINONDERIVATE ENTHALTENDE HEMMER VON NF-kB
US6395282B1 (en)	1998-04-16	2002-05-28	University Of Rochester	Immunogenic conjugates of Gram-negative bacterial autoinducer molecules
HRP990246A2 (en) *	1998-08-07	2000-06-30	Du Pont Pharm Co	Succinoylamino benzodiazepines as inhibitors of a beta protein production
US6117870A (en) *	1998-11-12	2000-09-12	Fujirebio Kabushiki Kaisha	Cyclic amide derivatives
EP1141011A2 (de)	1999-01-12	2001-10-10	Neorx Corporation	Verbindungen und methoden zur inhibierung oder erhöhung von entzündungsreaktionen
US6344450B1 (en) *	1999-02-09	2002-02-05	Bristol-Myers Squibb Company	Lactam compounds and their use as inhibitors of serine proteases and method
AU2001243601A1 (en) *	2000-03-10	2001-09-24	Ariad Pharmaceuticals, Inc.	Caprolactam derivatives and uses thereof

2004
- 2004-11-30 KR KR1020067010733A patent/KR101228268B1/ko not_active IP Right Cessation
- 2004-11-30 CA CA2547651A patent/CA2547651C/en not_active Expired - Fee Related
- 2004-11-30 US US10/581,274 patent/US20080227724A1/en not_active Abandoned
- 2004-11-30 WO PCT/GB2004/005030 patent/WO2005053702A2/en active Application Filing
- 2004-11-30 EP EP04798708A patent/EP1691814B9/de not_active Not-in-force
- 2004-11-30 PL PL04798708T patent/PL1691814T3/pl unknown
- 2004-11-30 SI SI200431939T patent/SI1691814T1/sl unknown
- 2004-11-30 CN CN2013103149649A patent/CN103393691A/zh active Pending
- 2004-11-30 ES ES04798708T patent/ES2390272T3/es active Active
- 2004-11-30 DK DK04798708.6T patent/DK1691814T3/da active
- 2004-11-30 EP EP10011516A patent/EP2279741A3/de not_active Withdrawn
- 2004-11-30 PT PT04798708T patent/PT1691814E/pt unknown
- 2004-11-30 TW TW093136880A patent/TWI356821B/zh not_active IP Right Cessation
- 2004-11-30 JP JP2006542002A patent/JP5248779B2/ja active Active
- 2004-12-01 AR ARP040104477A patent/AR047730A1/es not_active Application Discontinuation
2006
- 2006-05-23 IL IL175857A patent/IL175857A0/en unknown
2007
- 2007-02-21 HK HK07101966.1A patent/HK1094680A1/xx not_active IP Right Cessation
2012
- 2012-10-04 CY CY20121100921T patent/CY1113171T1/el unknown

Also Published As

Publication number	Publication date
EP2279741A3 (de)	2011-06-01
WO2005053702A2 (en)	2005-06-16
PT1691814E (pt)	2012-10-16
IL175857A0 (en)	2008-02-09
KR101228268B1 (ko)	2013-01-31
JP5248779B2 (ja)	2013-07-31
EP1691814B1 (de)	2012-07-25
TW200526585A (en)	2005-08-16
EP1691814B9 (de)	2013-02-20
ES2390272T3 (es)	2012-11-08
JP2007512387A (ja)	2007-05-17
EP2279741A2 (de)	2011-02-02
CN103393691A (zh)	2013-11-20
TWI356821B (en)	2012-01-21
EP1691814A2 (de)	2006-08-23
AR047730A1 (es)	2006-02-15
CY1113171T1 (el)	2016-04-13
DK1691814T3 (da)	2012-10-29
CA2547651A1 (en)	2005-06-16
WO2005053702A3 (en)	2005-09-15
SI1691814T1 (sl)	2012-11-30
PL1691814T3 (pl)	2012-12-31
US20080227724A1 (en)	2008-09-18
CA2547651C (en)	2015-06-23
KR20070018807A (ko)	2007-02-14

Publication	Publication Date	Title
HK1094680A1 (en)	2007-04-04	Anti-inflammatory agents
BE2018C008I2 (de)	2021-02-04
ZA200309887B (en)	2004-07-20	Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
WO2001019828A3 (en)	2001-10-04	Kinase inhibitors as therapeutic agents
BR0210030A (pt)	2004-08-10	Derivado de fenilpiridinacarbonilpiperazina
MXPA04001323A (es)	2004-05-20	Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso.
GB0127903D0 (en)	2002-01-16	Improvements relating to organic compounds
DK0918776T3 (da)	2004-07-12	Totalsyntese af antitumor acylfulvener
HK1100659A1 (en)	2007-09-28	Hiv protease inhibiting compounds hiv
DK0994108T3 (da)	2003-08-18	Fremgangsmåde til fremstilling af 2-hydroxybenzamidderivater
NO20002589D0 (no)	2000-05-19	Bifenylamidinderivater
EP1362844A4 (de)	2004-05-26	Benzylaminanalogon
DOP2002000371A (es)	2002-10-15	Fenil-heterociclil-eteres
HK1064673A1 (en)	2005-04-08	Fused-polycyclic compounds
HK1037617A1 (en)	2002-02-15	Process for the preparation of imidazodiazepine intermediates
WO2003075928A3 (en)	2003-12-04	Stable pharmaceutical compositions
ATE328954T1 (de)	2006-06-15	Stabilisatormischung
DK1072601T3 (da)	2004-12-20	4-Arylpiperidinderivater til behandling af pruritus
MY130817A (en)	2007-07-31	Herbicides
AP2001002314A0 (en)	2001-12-31	Substituted benzolactam compounds.
DK1424321T3 (da)	2006-07-31	Syntese af optisk aktive cyclohexylphenylglycolsyreestere
WO2001052824A3 (de)	2002-03-07	Verwendung spezieller verbindungen zur prophylaxe und therapie von hepatitis c
EP1557407A4 (de)	2006-11-15	Neue alpha-ketoamidderivate und deren verwendung
DE69615814D1 (de)	2001-11-15	Uch-15-verbindungen

Legal Events

Date	Code	Title	Description
2015-12-04	PS	Patent surrendered
2016-04-08	PS	Patent surrendered